Risk of hypertension in Cancer patients treated with Abiraterone: a meta-analysis

Mostrar otras versiones (1)

BACKGROUND: Hypertension is one of the major side effects associated with abiraterone in the treatment of advanced prostate cancer. The specific contribution of abiraterone to hypertension has not been defined. We performed a systematic review and meta-analysis of randomized clinical trials to deter...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiaolei, Wu, Shenhong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442407/
https://www.ncbi.nlm.nih.gov/pubmed/30984412
http://dx.doi.org/10.1186/s40885-019-0110-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6442407/
https://www.ncbi.nlm.nih.gov/pubmed/30984412
http://dx.doi.org/10.1186/s40885-019-0110-3

Ejemplares similares